{"id":"W3124229040","doi":"10.1200/jco.2021.39.3_suppl.299","title":"Zanidatamab (ZW25) in HER2-positive biliary tract cancers (BTCs): Results from a phase I study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Cohort; Adverse effect; Immunohistochemistry; Trastuzumab; Oncology; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Gallbladder; Chemotherapy; Surgery; Phases of clinical research; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459183,0.0008155797,0.0008612055,0.0003725434,0.0002525997,0.0007026386,0.0006178159,0.0006502601,0.00303856],"category_scores_gemma":[0.0006517007,0.0003583939,0.0009608279,0.0004878597,0.0004212316,0.0004720906,0.0002519402,0.001181504,0.0009048458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000792444,"about_ca_system_score_gemma":0.001342494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002191523,"about_ca_topic_score_gemma":0.008086865,"domain_scores_codex":[0.9997548,0.00009656191,0.0000194812,0.00003695619,0.00004040799,0.00005184621],"domain_scores_gemma":[0.9995826,0.00005398805,0.0001098565,0.0000275876,0.00003408493,0.000191844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3264048,0.07649012,0.03461793,0.003545974,0.005122816,0.001221388,0.0008168256,0.005822153,0.1427361,0.0006368631,0.02587973,0.3767053],"study_design_scores_gemma":[0.4595012,0.4174916,0.08113586,0.0002791605,0.002931539,0.002391692,0.0002475268,0.002321223,0.01242561,0.0004267534,0.02076875,0.00007916905],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798503,0.008671373,0.0007979803,0.0005178165,0.00007879597,0.002808862,0.004061066,0.0001156076,0.003098188],"genre_scores_gemma":[0.9723665,0.008799376,0.002336499,0.001187369,0.00008256397,0.001648216,0.01045207,0.00005105821,0.003076399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00303856,"threshold_uncertainty_score":0.01016498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1374272635865832,"score_gpt":0.4865471462798224,"score_spread":0.3491198826932391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}